Emerging Infectious Diseases

The study was conducted on patients with type 2 diabetes in Sulaymaniyah Governorate for the period from September 2018 to May 2019. The aim of the study was to evaluate the level of irisin hormone and triglycerides in both males and females with type 2 diabetes and compare them with healthy people. As (50) blood samples were collected from people in Sulaymaniyah governorate, which included two groups and by (30) samples from people with diabetes (males and females) and (20) samples from healthy people (males and females), which were considered as a control group, their ages ranged between 30 and 60 years old. The estimation of the concentrations of both irisin hormone, and triglycerides was studied, where the patients were divided into two groups, the first group whose ages ranged from (30-45), the second (45-60). The results showed a significant increase (P ≤ 0.05) in the concentrations of irisin hormone in Blood serum in patients with type 2 diabetes compared to its concentrations in healthy subjects. Also, there was no significant difference in the concentrations of irisin hormone, triglycerides between male and female patients with type 2 diabetes. The results also indicated that there was a significant difference at the level (P ≤ 0.05) in the concentrations of triglycerides in the blood serum of patients with type 2 diabetes compared to its concentrations in healthy people. On the other hand, there was no significant difference in the concentrations of irisin hormone, triglycerides, between the two age groups of patients with type 2 diabetes.